Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins
- PMID: 35008940
- PMCID: PMC8745615
- DOI: 10.3390/ijms23010514
Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins
Abstract
Acute myeloid leukemia (AML), the most common form of an acute leukemia, is a malignant disorder of stem cell precursors of the myeloid lineage. Ubiquitination is one of the post-translational modifications (PTMs), and the ubiquitin-like proteins (Ubls; SUMO, NEDD8, and ISG15) play a critical role in various cellular processes, including autophagy, cell-cycle control, DNA repair, signal transduction, and transcription. Also, the importance of Ubls in AML is increasing, with the growing research defining the effect of Ubls in AML. Numerous studies have actively reported that AML-related mutated proteins are linked to Ub and Ubls. The current review discusses the roles of proteins associated with protein ubiquitination, modifications by Ubls in AML, and substrates that can be applied for therapeutic targets in AML.
Keywords: ISGylation; NEDDylation; SUMOylation; deubiquitination; ubiquitination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
A Critical Role for ISGylation, Ubiquitination and, SUMOylation in Brain Damage: Implications for Neuroprotection.Neurochem Res. 2020 Sep;45(9):1975-1985. doi: 10.1007/s11064-020-03066-3. Epub 2020 Jun 4. Neurochem Res. 2020. PMID: 32500407 Review.
-
Ubiquitin-like modifications in the DNA damage response.Mutat Res. 2017 Oct;803-805:56-75. doi: 10.1016/j.mrfmmm.2017.07.001. Epub 2017 Jul 11. Mutat Res. 2017. PMID: 28734548 Review.
-
[Ubiquitins, proteasomes, sumoylation and application today and in future for cancer and other diseases therapy II. Sumoylation and neddylation as posttranslational modifications of proteins and their ubiquitinylation and its significance].Vnitr Lek. 2006 Jun;52(6):619-27. Vnitr Lek. 2006. PMID: 16871767 Review. Czech.
-
Ubiquitin-like proteins in the DNA damage response: the next generation.Essays Biochem. 2020 Oct 26;64(5):737-752. doi: 10.1042/EBC20190095. Essays Biochem. 2020. PMID: 32451552 Review.
-
Ubiquitin and Ubiquitin-like proteins in cardiac disease and protection.Curr Drug Targets. 2018;19(9):989-1002. doi: 10.2174/1389450117666151209114608. Curr Drug Targets. 2018. PMID: 26648080 Free PMC article. Review.
Cited by
-
Implementation of Machine Learning-Based System for Early Diagnosis of Feline Mammary Carcinomas through Blood Metabolite Profiling.Metabolites. 2024 Sep 17;14(9):501. doi: 10.3390/metabo14090501. Metabolites. 2024. PMID: 39330508 Free PMC article.
-
The roles of ubiquitination in AML.Ann Hematol. 2024 Sep;103(9):3413-3428. doi: 10.1007/s00277-023-05415-y. Epub 2023 Aug 21. Ann Hematol. 2024. PMID: 37603061 Review.
-
Almost 50 Years of Monomeric Extracellular Ubiquitin (eUb).Pharmaceuticals (Basel). 2024 Jan 31;17(2):185. doi: 10.3390/ph17020185. Pharmaceuticals (Basel). 2024. PMID: 38399400 Free PMC article. Review.
-
Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia.Front Immunol. 2025 Apr 4;16:1513040. doi: 10.3389/fimmu.2025.1513040. eCollection 2025. Front Immunol. 2025. PMID: 40255396 Free PMC article.
-
N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.Mol Cancer. 2024 May 31;23(1):116. doi: 10.1186/s12943-024-02013-y. Mol Cancer. 2024. PMID: 38822351 Free PMC article.
References
-
- Juliusson G., Hough R. Leukemia. Prog. Tumor. Res. 2016;43:87–100. - PubMed
-
- Nishikata I., Sasaki H., Iga M., Tateno Y., Imayoshi S., Asou N., Nakamura T., Morishita K. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood. 2003;102:3323–3332. doi: 10.1182/blood-2002-12-3944. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous